DRAEGERWERK AG - PREF (DRW3.DE) Stock Fundamental Analysis
Europe - FRA:DRW3 - DE0005550636
65 EUR
0 (0%)
DRW3 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. DRW3 has only an average score on both its financial health and profitability. DRW3 has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally DRW3 also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
DRW3 had positive earnings in the past year.
DRW3 had a positive operating cash flow in the past year.
Of the past 5 years DRW3 4 years were profitable.
DRW3 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
DRW3 has a Return On Assets (3.35%) which is in line with its industry peers.
DRW3 has a Return On Equity of 6.84%. This is comparable to the rest of the industry: DRW3 outperforms 55.00% of its industry peers.
DRW3 has a Return On Invested Capital (6.55%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.35% | ||
| ROE | 6.84% | ||
| ROIC | 6.55% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of DRW3 (2.98%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DRW3 has grown nicely.
Looking at the Operating Margin, with a value of 5.12%, DRW3 is doing worse than 63.33% of the companies in the same industry.
DRW3's Operating Margin has improved in the last couple of years.
DRW3 has a Gross Margin of 44.86%. This is in the lower half of the industry: DRW3 underperforms 63.33% of its industry peers.
DRW3's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.12% | ||
| PM (TTM) | 2.98% | ||
| GM | 44.86% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
DRW3 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DRW3 has less shares outstanding than it did 1 year ago.
DRW3 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRW3 has an improved debt to assets ratio.
2.2 Solvency
DRW3 has an Altman-Z score of 2.64. This is not the best score and indicates that DRW3 is in the grey zone with still only limited risk for bankruptcy at the moment.
DRW3 has a Altman-Z score (2.64) which is comparable to the rest of the industry.
DRW3 has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as DRW3 would need 3.51 years to pay back of all of its debts.
DRW3 has a Debt to FCF ratio of 3.51. This is in the better half of the industry: DRW3 outperforms 75.00% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that DRW3 is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.16, DRW3 is doing good in the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.64 |
ROIC/WACC1.01
WACC6.51%
2.3 Liquidity
DRW3 has a Current Ratio of 1.74. This is a normal value and indicates that DRW3 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DRW3 (1.74) is comparable to the rest of the industry.
DRW3 has a Quick Ratio of 1.03. This is a normal value and indicates that DRW3 is financially healthy and should not expect problems in meeting its short term obligations.
DRW3 has a Quick ratio (1.03) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
DRW3 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.14%.
The Earnings Per Share has been growing by 36.42% on average over the past years. This is a very strong growth
The Revenue has decreased by -0.03% in the past year.
The Revenue has been growing slightly by 3.92% on average over the past years.
EPS 1Y (TTM)-14.14%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-57.73%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.6%
3.2 Future
The Earnings Per Share is expected to grow by 6.28% on average over the next years.
The Revenue is expected to grow by 2.75% on average over the next years.
EPS Next Y2.66%
EPS Next 2Y10.17%
EPS Next 3Y11.87%
EPS Next 5Y6.28%
Revenue Next Year2.76%
Revenue Next 2Y3.42%
Revenue Next 3Y3.63%
Revenue Next 5Y2.75%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DRW3 is valuated correctly with a Price/Earnings ratio of 12.20.
DRW3's Price/Earnings ratio is rather cheap when compared to the industry. DRW3 is cheaper than 95.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of DRW3 to the average of the S&P500 Index (27.86), we can say DRW3 is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.01, the valuation of DRW3 can be described as very reasonable.
Based on the Price/Forward Earnings ratio, DRW3 is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DRW3 to the average of the S&P500 Index (23.32), we can say DRW3 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.2 | ||
| Fwd PE | 9.01 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DRW3 is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DRW3 is valued cheaply inside the industry as 96.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.56 | ||
| EV/EBITDA | 4.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.59
PEG (5Y)0.33
EPS Next 2Y10.17%
EPS Next 3Y11.87%
5. Dividend
5.1 Amount
DRW3 has a Yearly Dividend Yield of 3.77%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.13, DRW3 pays a better dividend. On top of this DRW3 pays more dividend than 96.67% of the companies listed in the same industry.
DRW3's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.77% |
5.2 History
On average, the dividend of DRW3 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DRW3 pays out 37.56% of its income as dividend. This is a sustainable payout ratio.
The dividend of DRW3 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP37.56%
EPS Next 2Y10.17%
EPS Next 3Y11.87%
FRA:DRW3 (10/6/2025, 5:29:26 PM)
65
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.49%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.22B
Analysts76
Price Target91.43 (40.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.77% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP37.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.7%
PT rev (3m)6.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.17%
EPS NY rev (3m)1.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.53%
Revenue NY rev (3m)-1.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.2 | ||
| Fwd PE | 9.01 | ||
| P/S | 0.36 | ||
| P/FCF | 9.56 | ||
| P/OCF | 6.4 | ||
| P/B | 0.83 | ||
| P/tB | 1.08 | ||
| EV/EBITDA | 4.4 |
EPS(TTM)5.33
EY8.2%
EPS(NY)7.22
Fwd EY11.1%
FCF(TTM)6.8
FCFY10.46%
OCF(TTM)10.16
OCFY15.63%
SpS179.14
BVpS78.08
TBVpS59.93
PEG (NY)4.59
PEG (5Y)0.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.35% | ||
| ROE | 6.84% | ||
| ROCE | 8.71% | ||
| ROIC | 6.55% | ||
| ROICexc | 7.37% | ||
| ROICexgc | 9.14% | ||
| OM | 5.12% | ||
| PM (TTM) | 2.98% | ||
| GM | 44.86% | ||
| FCFM | 3.79% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-18.01%
ROICexcg growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score6
Asset Turnover1.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 0.73 | ||
| Cap/Depr | 42.96% | ||
| Cap/Sales | 1.88% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 59.72% | ||
| Profit Quality | 127.24% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.64 |
F-Score6
WACC6.51%
ROIC/WACC1.01
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.14%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-57.73%
EPS Next Y2.66%
EPS Next 2Y10.17%
EPS Next 3Y11.87%
EPS Next 5Y6.28%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.6%
Revenue Next Year2.76%
Revenue Next 2Y3.42%
Revenue Next 3Y3.63%
Revenue Next 5Y2.75%
EBIT growth 1Y-8.56%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.51%
EBIT Next 3Y29.6%
EBIT Next 5Y12.23%
FCF growth 1Y1126.79%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y201.26%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%